Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity (Q28276393)

2

0 references

D Saroff

3

0 references

A Lorenzo

4

0 references

M Yuan

5

0 references

B A Yankner

https://scigraph.springernature.com/pub.10.1038/nm0798-827

6

0 references

language of work or name

English

0 references

publication date

July 1998

0 references

published in

Nature Medicine

0 references

volume

4

0 references

issue

7

0 references

page(s)

827-31

0 references

exact match

0 references

cites work

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1038/NM0798-827

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 April 2017

2 references

https://api.crossref.org/works/10.1038/NM0798-827

21 April 2017

https://api.crossref.org/works/10.1038%2FNM0798-827

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Methodological variables in the assessment of beta amyloid neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Formation of beta-amyloid protein deposits in brains of transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Senile plaques in cortex of aged normal monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Microtubule-associated protein tau, paired helical filaments, and phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Effects of injected Alzheimer beta-amyloid cores in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Amyloid in the brains of aged squirrel monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021

A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-827

7 January 2021